Gene · 3239
Papers1,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 1,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel chromosome 2q24.3-q32.1 microdeletion in a fetus with multiple malformations. | J Clin Lab Anal | 2022 | 35819063 | PubTator, text mining | PubMed |
| Machine learning techniques for identification of carcinogenic mutations, which cause breast adenocarcinoma. | Sci Rep | 2022 | 35817838 | PubTator, text mining | PubMed |
| Matrix Metalloproteinases and Their Inhibitors in Pulmonary Fibrosis: EMMPRIN/CD147 Comes into Play. | Int J Mol Sci | 2022 | 35805895 | PubTator, text mining | PubMed |
| Precision Medicine in Solid Tumors: How Far We Traveled So Far? | Cancers (Basel) | 2022 | 35804974 | PubTator, text mining | PubMed |
| GFI1B acts as a metabolic regulator in hematopoiesis and acute myeloid leukemia. | Leukemia | 2022 | 35804097 | PubTator, text mining | PubMed |
| Urinary extracellular vesicle as a potential biomarker of exercise-induced fatigue in young adult males. | Eur J Appl Physiol | 2022 | 35781843 | PubTator, text mining | PubMed |
| Differential Immune Checkpoint and Ig-like V-Type Receptor Profiles in COVID-19: Associations with Severity and Treatment. | J Clin Med | 2022 | 35743356 | PubTator, text mining | PubMed |
| Novel Biomarkers, Diagnostic and Therapeutic Approach in Rheumatoid Arthritis Interstitial Lung Disease-A Narrative Review. | Biomedicines | 2022 | 35740390 | PubTator, text mining | PubMed |
| Diagnostic Accuracy of Liquid Biomarkers in Airway Diseases: Toward Point-of-Care Applications. | Front Med (Lausanne) | 2022 | 35733871 | PubTator, text mining | PubMed |
| Soluble PD-L1 in blood correlates positively with neutrophil and negatively with lymphocyte mRNA markers and implies adverse sepsis outcome. | Immunol Res | 2022 | 35732880 | PubTator, text mining | PubMed |
| The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response. | Cancer Res | 2022 | 35731919 | PubTator, text mining | PubMed |
| Identification of genetic polymorphisms in unexplained recurrent spontaneous abortion based on whole exome sequencing. | Ann Transl Med | 2022 | 35722368 | PubTator, text mining | PubMed |
| Soluble PD-L1 Expression After Intravenous Treatment of Cancer Patients With Selenite in Phase I Clinical Trial. | Front Oncol | 2022 | 35720000 | PubTator, text mining | PubMed |
| Identification of HOX signatures contributing to oral cancer phenotype. | Sci Rep | 2022 | 35710803 | PubTator, text mining | PubMed |
| Recurrent chromosomal translocations in sarcomas create a megacomplex that mislocalizes NuA4/TIP60 to Polycomb target loci. | Genes Dev | 2022 | 35710139 | PubTator, text mining | PubMed |
| Characterization of multiple soluble immune checkpoints in individuals with different Mycobacterium tuberculosis infection status and dynamic changes during anti-tuberculosis treatment. | BMC Infect Dis | 2022 | 35701741 | PubTator, text mining | PubMed |
Successful Treatment with Short-Term Steroid Against Severe Hepatitis Confirmed by Liver Biopsy in a Patient with Advanced Squamous-Cell Lung Cancer Receiving a Combination of Pembrolizumab, Carboplatin, and Nab-Paclitaxel: A Case Report. | Onco Targets Ther | 2022 | 35698605 | PubTator, text mining | PubMed |
| Integrated multi-omics reveal polycomb repressive complex 2 restricts human trophoblast induction. | Nat Cell Biol | 2022 | 35697783 | PubTator, text mining | PubMed |
| Unbalanced expression of sICOS and sPD-1 correlates with tumor progression in gastric cancer. | J Surg Oncol | 2022 | 35689579 | PubTator, text mining | PubMed |
| Blood Biomarkers of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer. | J Clin Med | 2022 | 35683629 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3239/papers?page=23